Emergo Therapeutics Competitors and Similar CompaniesClear all
Emergo Therapeutics's competitors and similar companies include MindMed, Siegfried Hameln, Novartis France and Shanghai Shenqi Pharmaceutical.
 Emergo Therapeutics Emergo Therapeutics is a biopharmaceutical company specializing in developing drugs to modulate inflammatory cytokines. |  MindMed MindMed is a neuro-pharmaceutical company focused on discovering and developing medicines based on psychedelics. |  Siegfried Hameln Siegfried Hameln is a company that manufactures, tests, and packages medicinal products. |  Novartis France Novartis France (also known as Novartis Pharma) is a company developing medical treatments. |  Shanghai Shenqi Pharmaceutical Shenqi Pharmaceutical (also known as Shanghai Shenqi Pharmaceutical Investment Management, 神奇制药投资管理股份有限公司) is a pharmaceutical holding company specialized in the research, manufacturing, and distribution of medicine. | |
Founding Date | Founding Date 2017 | Founding Date 2019 | Founding Date 1950 | Founding Date 1997 | Founding Date 1983 |
Type | Type Private | Type Private | Type Subsidiary | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Durham, US HQ | Locations New York, US HQ | Locations Hameln, DE HQ | Locations Rueil-Malmaison, FR HQ | Locations Shanghai, CN HQ |
Employees | Employees 5 | Employees 1092% decrease | Employees 412% decrease | Employees 5282% increase | Employees 1,26611% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) €100.5m (FY, 2020) | Revenue (est.) €2.3b (FY, 2021) | Revenue (est.) ¥2b (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods €35.1m (FY, 2020) | Cost of goods €1.4b (FY, 2021) | Cost of goods ¥1.1b (FY, 2024) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit €65.4m (FY, 2020) | Gross profit €844.1m (FY, 2021) | Gross profit ¥946.8m (FY, 2024) |
Net income | Net income N/A | Net income N/A | Net income €9.6m (FY, 2020) | Net income €47m (FY, 2021) | Net income ¥66.1m (FY, 2024) |
Funding | |||||
Latest funding round | Latest funding round $ 12m (almost 8 years ago) | Latest funding round $ 6.2m (over 6 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 12m | Total funding raised $ 6.2m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
MindMed
HQ
New York, US
Employees
109↓ 2% decrease
MindMed is a neuro-pharmaceutical company focused on discovering and developing medicines based on psychedelics.
View companySiegfried Hameln
HQ
Hameln, DE
Siegfried Hameln is a company that manufactures, tests, and packages medicinal products.
View companyNovartis France
HQ
Rueil-Malmaison, FR
Novartis France (also known as Novartis Pharma) is a company developing medical treatments.
View companyShanghai Shenqi Pharmaceutical
HQ
Shanghai, CN
Employees
1,266↓ 11% decrease
Shenqi Pharmaceutical (also known as Shanghai Shenqi Pharmaceutical Investment Management, 神奇制药投资管理股份有限公司) is a pharmaceutical holding company specialized in the research, manufacturing, and distribution of medicine.
View company